cysteine has been researched along with tegafur in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawabata, N; Nakashima, T; Ohno, H; Yano, K | 2 |
Hoshi, A; Iigo, M; Kitagawa, H | 1 |
De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
Kawabata, N; Kitagawa, H; Kuwamura, T; Satoh, T; Sugiyama, S | 1 |
5 other study(ies) available for cysteine and tegafur
Article | Year |
---|---|
Effect of L-cysteine on plasma concentration and urinary excretion of 1-(tetrahydro-2-furanyl)-5-fluorouracil metabolites.
Topics: Animals; Cysteine; Fluorouracil; Kidney Tubules; Male; Rats; Rats, Inbred Strains; Tegafur | 1991 |
Effect of L-cysteine on distribution volume of 1-(tetrahydro-2-furanyl)-5-fluorouracil.
Topics: Animals; Cysteine; Drug Interactions; Extracellular Space; Male; Rats; Rats, Inbred Strains; Tegafur; Time Factors | 1990 |
Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with L-cystine.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Cysteine; Cystine; Drug Synergism; Fluorouracil; Male; Mice; Mice, Inbred Strains; Tegafur | 1986 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cysteine; Drug Evaluation, Preclinical; Drug Synergism; Fluorouracil; Male; Mice; Tegafur | 1987 |
Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
Topics: Absorption; Animals; Antineoplastic Agents; Biotransformation; Cysteine; Fluorouracil; Kinetics; Lethal Dose 50; Male; Mice; Microsomes, Liver; Rats; Rats, Inbred Strains; Tegafur | 1983 |